S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009

A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes. view all titles (2)

All Bill Titles

  • Official: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes. as introduced.
  • Short: Pharmaceutical Market Access and Drug Safety Act of 2009 as introduced.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

Bill’s Views

  • Today: 2
  • Past Seven Days: 8
  • All-Time: 9,621
 
Introduced
 
Senate
Passes
 
House
Passes
 
President
Signs
 

 
03/04/09
 
 
 
 
 
 
 

Official Summary

Pharmaceutical Market Access and Drug Safety Act of 2009 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States.

Official Summary

Pharmaceutical Market Access and Drug Safety Act of 2009 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States. Prohibits the importation of a qualifying drug unless such drug is imported by:
(1) a registered importer; or
(2) an individual for personal use. Establishes registration conditions for importers and exporters. Requires the Secretary of Health and Human Services to inspect places of business, verify chains of custody, inspect facilities, and determine compliance with registration conditions. Sets forth provisions governing the importation of qualifying drugs that are different from U.S. label drugs, including standards for judging such differences. Prohibits manufacturers from:
(1) discriminating against registered exporters or importers;
(2) causing there to be a difference in a prescription drug distributed in the United States and one distributed in a permitted country;
(3) engaging in actions to restrict, prohibit, or delay the importation of a qualifying drug; or
(4) engaging in any action that the Federal Trade Commission (FTC) determines discriminates against a person that engages or attempts to engage in the importation of a qualifying drug. States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement. Requires the Secretary to educate consumers regarding prescription drug importation. Sets forth provisions governing the sale of prescription drugs through an Internet site. Includes the dispensing or selling of a prescription drug in violation of this Act as a prohibited act under FFDCA. Prohibits the introduction of restricted transactions with unregistered foreign pharmacies into a payment system or the completion of such transactions using a payment system.

...Read the Rest

Organizations Supporting S.525

  • National Federation of Independent Business
  • American Academy of Family Physicians
  • National Farmers Union
  • Telephone Pioneer Family Campers
  • National Retiree Legislative Network
  • National Education Association
  • ...and 2 more. See all.

Organizations Opposing S.525

  • Pharmaceutical Research and Manufacturers of America
  • Academy of Managed Care Pharmacy
  • ALS Association
  • American Association for Homecare
  • American Pharmacists Association
  • Amerinet
  • ...and 38 more. See all.




Vote on This Bill

67% Users Support Bill

2 in favor / 1 opposed
 

Send Your Senator a Letter

about this bill Support Oppose Tracking
Track with MyOC